Offer - Urjas Oil for just ₹ 1 X
Renol O is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Renol O have also been mentioned below.
The optimal dosage of Renol O is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Renol O include Dry Mouth, Dizziness, Muscle Ache. While these are the most often observed Renol O side effects, there are can be others also. These have been listed below. Usually, these side effects of Renol O go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Renol O has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Renol O's effects on the liver, heart and kidney are discussed below in the Renol O related warnings section.
Renol O can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Renol O in conditions like Liver Disease, Kidney Disease, Osteoporosis.
Drug reaction of Renol O with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Renol O is not safe while driving, and is is not addictive in nature.
Renol O is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Renol O safe for pregnant women?
Renol O can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Renol O safe during breastfeeding?
Taking Renol O may lead to serious side effects if you are breastfeeding. Renol O should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Renol O on the Kidneys?
Kidney can be affected by Renol O. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Renol O on the Liver?
Renol O can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Renol O on the Heart?
Renol O may have mild side effects on the heart. Most people will never see any effect on the heart.
Renol O should not be taken with following medicines due to severe side effects it may cause to patients -
Unknown
If you are suffering from any of the following diseases, you should not take Renol O unless your doctor advises you to do so -
Is this Renol O habit forming or addictive?
Renol O does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Renol O you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Renol O is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Renol O for mental disorders.
Interaction between Food and Renol O
Due to the absence of research, it is difficult to say how Renol O and food will interact.
Interaction between Alcohol and Renol O
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Renol O.
Renol O contains domperidone (dopamine D2-receptor antagonist). It works by inhibiting the neurotransmitter dopamine (a chemical messenger present in our body) from acting on the vomiting center present in the brain thus preventing nausea and vomiting which provides relief to the patient from nausea and vomiting.
No, Renol O does not cause high blood sugar (hyperglycemia). It has not been reported by the patients who are taking it. You are advised to monitor your blood sugar level on daily basis. If you notice high blood sugar levels after taking this drug, then discuss it with your doctor who might change the dosage of your current medications.
Renol O is a brand name for domperidone. It is a prescription drug which belongs to the class of medication known as antiemetics (dopamine D2-receptor antagonist). It is mainly used for the treatment of nausea, vomiting, bloating and stomach fullness. It is also used to prevent nausea and vomiting caused by certain medication used to treat Parkinson's disease.
Yes, you can take Renol O for acidity as it decreases the release of acid in your stomach which is responsible for acidity, burping, and discomfort in your stomach. You are advised to take it before a meal or as prescribed by your doctor.
Yes, Renol O can cause headache, this occurs rarely. It is a known side effect of this drug. However, the exact cause behind this is unknown. If you experience severe headache after taking this drug, consider taking a mild painkiller, applying balms and complete rest, even after this if pain does not subside then discuss with your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 666-667
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1310-1311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prilosec (omeprazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 651-653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 945-947